Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Yoshida

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Anticancer Research|January 30, 2026
Delayed Initiation of S-1 Adjuvant Chemotherapy Impairs Survival in Patients With Curatively Resected Pancreatic CancerDongha Lee, Hirochika Toyama, Yoshihide Nanno, et al.
Anticancer Research|December 31, 2024
Treatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular CarcinomaNobuaki Ishihara, Shohei Komatsu, Yoshihiko Yano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of resection of a metastatic liver tumor that recurred after particle beam therapy]Toshihiko Yoshida, Atsushi Takebe, Takumi Fukumoto, et al.
World Journal of Clinical Cases|February 5, 2024
Utility of plasma D-dimer for diagnosis of venous thromboembolism after hepatectomyTaiichiro Miyake, Hiroaki Yanagimoto, Daisuke Tsugawa, et al.
Anticancer Research|April 27, 2024
Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular CarcinomaAkira Koizumi, Shohei Komatsu, Satoshi Omiya, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Anticancer Research|January 30, 2026
Delayed Initiation of S-1 Adjuvant Chemotherapy Impairs Survival in Patients With Curatively Resected Pancreatic CancerDongha Lee, Hirochika Toyama, Yoshihide Nanno, et al.
Anticancer Research|December 31, 2024
Treatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular CarcinomaNobuaki Ishihara, Shohei Komatsu, Yoshihiko Yano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of resection of a metastatic liver tumor that recurred after particle beam therapy]Toshihiko Yoshida, Atsushi Takebe, Takumi Fukumoto, et al.
World Journal of Clinical Cases|February 5, 2024
Utility of plasma D-dimer for diagnosis of venous thromboembolism after hepatectomyTaiichiro Miyake, Hiroaki Yanagimoto, Daisuke Tsugawa, et al.
Anticancer Research|April 27, 2024
Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular CarcinomaAkira Koizumi, Shohei Komatsu, Satoshi Omiya, et al.
Pageof 8